Pediatric AML: Clinical Trials

1 trial for Pediatric AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
Idarubicin Hydrochloride, Fludarabine, Cytarabine (Ara-C) - Acute Myeloid Leukemia, Pediatric AML
Early Phase 1RecruitingBaylor College of Medicine362025-10-222026-08-24

Narrower conditions

Leukemia, Myeloid, Acute (1)  ·  Neoplasm, Residual (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Cytarabine (1)  ·  Etoposide (1)  ·  Idarubicin (1)  ·  asparaginase erwinia chrysanthemi recombinant (1)  ·  fludarabine (1)  ·  venetoclax (1)

Sponsors

Baylor College of Medicine (1)

Countries

United States (1)